GeoVax (GOVX), Marin (MRIN) & SunLink (SSY) stocks in spotlight Friday

3 min read | August 20, 2021 01:05 PM PDT | By Team Kalkine Media

Highlights

  • GeoVax Labs, Inc. (NASDAQ:GOVX) stock was up 52.10% at 10:59 am ET.
  • Marin Software (MRIN) stock was up 14.12% at 11:01 am ET.
  • SunLink Health Systems, Inc. (SSY) rose 2.40% at 11:02 am ET.

The stocks of GeoVax Labs, Inc. (NASDAQ:GOVX), Marin Software Incorporated (MRIN) and SunLink Health Systems, Inc. (SSY) were trading higher on Friday.

GOVX was up 52.10% to US$6.5401 at 10:59 am ET, MRIN stock rose 14.12% to US$5.489 at 11:01 am ET, and SSY shares gained 2.40% to US$2.6625 at 11:02 am ET.

Healthcare, technology, and consumer stocks have been drawing attention after better-than-expected quarterly results of many companies in these sectors recently.

Here we explore three stocks that are drawing attention on Friday.

GeoVax Labs, Inc.

GeoVax is a biotechnology company and develops vaccines for cancer and other diseases. Its market cap is US$40 million. In the June quarter of 2021, its revenue was US$79.7 thousand compared to US$440.6 thousand in the year-ago quarter. Its net loss was US$1.3 million or 0.21 per share diluted against US$0.455 million or US$0.66 per share diluted in the year-ago quarter.

On Aug 19, its trading volume was 22,914,430 compared to the previous day’s 765,560.

The interest in the stock could be due to its covid vaccine data presentation to the European medicine fraternity. The company is conducting studies for preventive covid vaccines.

The stock price rose to US$4.3 on Aug 19 from US$4.03 on Aug 18.

Also Read: Will they weather the volatile market? Eight tech ETFs to explore

Source – pixabay

Also Read: How Taliban’s Afghan victory could affect the global rare-earth market

Marin Software Incorporated


Its market capitalization is US$84 million. The technology company provides cloud-based digital advertising management solutions to improve business decisions.

Its revenue for the June quarter, 2021, was US$6.09 million compared to US$7.28 million in the same quarter the previous year. The net loss was US$2.5 million or US$0.23 per share diluted compared to the net loss of US$3.5 million or US$0.50 per share diluted.

On Aug 19, Marin had announced integration with Criteo’s commerce media platform, a probable reason for investors’ interest in the stock.

Marin’s stock price rose to US$4.81 on Aug 19 from US$5.18 on Aug 18.

Also Read: Top semiconductor stocks to watch out amid global chip supply shortage

SunLink Health Systems, Inc.

Its market capitalization is US$19 million. SunLink provides retail pharmacy services. For the quarter ended March 31, 2021, the revenue for the company was US$9.8 million compared to US$12.67 million in the same quarter the previous year.


Its net loss was US$531 thousand or US$0.08 per share diluted compared to US$158 thousand or US$0.02 per share diluted in the same quarter of 2020. The trading volume rose to 681,308 on Aug 19 from 469,881 on Aug 18, 2021. The stock closed at US$2.6 on Aug 19.

Also Read: Top nine transportation stocks based on their market capitalization

Bottomline

The stock market has been volatile of late due to factors like rising delta infections and inflation. However, technology and pharma stocks continue to draw investors’ attention. These sectors are expected to see strong growth in the coming quarters as the economy improves.


Disclaimer

The content, including but not limited to any articles, news, quotes, information, data, text, reports, ratings, opinions, images, photos, graphics, graphs, charts, animations and video (Content) is a service of Kalkine Media LLC (Kalkine Media, we or us) and is available for personal and non-commercial use only. The principal purpose of the Content is to educate and inform. The Content does not contain or imply any recommendation or opinion intended to influence your financial decisions and must not be relied upon by you as such. Some of the Content on this website may be sponsored/non-sponsored, as applicable, but is NOT a solicitation or recommendation to buy, sell or hold the stocks of the company(s) or engage in any investment activity under discussion. Kalkine Media is neither licensed nor qualified to provide investment advice through this platform. Users should make their own enquiries about any investments and Kalkine Media strongly suggests the users to seek advice from a financial adviser, stockbroker or other professional (including taxation and legal advice), as necessary. Kalkine Media hereby disclaims any and all the liabilities to any user for any direct, indirect, implied, punitive, special, incidental or other consequential damages arising from any use of the Content on this website, which is provided without warranties. The views expressed in the Content by the guests, if any, are their own and do not necessarily represent the views or opinions of Kalkine Media. Some of the images/music that may be used on this website are copyright to their respective owner(s). Kalkine Media does not claim ownership of any of the pictures/music displayed/used on this website unless stated otherwise. The images/music that may be used on this website are taken from various sources on the internet, including paid subscriptions or are believed to be in public domain. We have used reasonable efforts to accredit the source (public domain/CC0 status) to where it was found and indicated it, as necessary.


Sponsored Articles


Investing Ideas

Previous Next